Charles Russell Speechlys has advised the founding shareholders on the MBO of Construction Materials Online Limited
Charles Russell Speechlys has advised the founding shareholders on the management buyout of Construction Materials Online Limited (CMO), backed by Leeds based private equity firm, Key Capital Partners.
Founded in 2008, Plymouth based CMO is an online retailer supplying building materials to DIY builders and building contractors. Having come from traditional merchant backgrounds, the four founders have grown CMO to a £25 million revenues business, in particular experiencing rapid growth with sales through its websites increasing by 55% in the last 12 months, and currently employing 40 staff.
CMO and its shareholders were also advised by GCA Altium, led by directors Katherine Hobbs and Sam Fuller.
Rob Kavanagh, co-Founder of CMO, said “Charles Russell Speechlys provided excellent support and legal advice to the founders throughout the transaction. The depth of the team’s commercial awareness, technical legal expertise, hard work and responsiveness was of great value to us and we would not hesitate to recommend them to others considering a company sale.”
Commenting on the transaction, Andrew Clarke, Corporate Partner at Charles Russell Speechlys said, “We are delighted to have advised the founding shareholders of CMO on the deal and it was a pleasure working with them and with GCA Altium. We look forward to seeing the business grow from strength to strength, both with the reinvestment by the founding shareholders and backing from Key Capital Partners.”
News & Insights
Charles Russell Speechlys advises AgDevCo on investment into Rwandan maize producer and on Ugandan joint venture
AgDevCo is a social impact investor and project developer operating exclusively in the agriculture sector in Sub-Saharan Africa.
Transparency as a rule
It is time to register in the Luxembourg Register of Effective Beneficiaries.
Charles Russell Speechlys advises Apposite Capital on their investment into Mirada Medical
Mirada is a leading AI software developer for streamlining cancer treatment planning applications.